Jan Best

2.4k citations

56 papers · 1.2k indexed · h-index 20

Impact in

Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Liver Disease and Transplantation
Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in ⓘ

Hepatology 38
- Hepatocellular Carcinoma Treatment and Prognosis 19
- Liver physiology and pathology 14
- Liver Disease and Transplantation 11
- Liver Diseases and Immunity 5
Epidemiology 32
- Liver Disease Diagnosis and Treatment 30
- Hepatitis B Virus Studies 3

Co-authors: Ali Canbay (28 shared papers)Guido Gerken (21 shared papers)Leo A. van Grunsven (10 shared papers)Lars P. Bechmann (16 shared papers)Paul Manka (16 shared papers)Jan‐Peter Sowa (11 shared papers)Laurent Dollé (8 shared papers)Svenja Sydor (10 shared papers)
Journals: Journal of Hepatology (3 papers)Scientific Reports (2 papers)Pharmaceuticals (2 papers)Journal of Clinical Medicine (2 papers)Cancer Immunology Immunotherapy (2 papers)
Partner nations: Germany United States Belgium

In The Last Decade

Jan Best

52 papers receiving 1.2k citations

Peers

Countries citing papers authored by Jan Best

Since Specialization

Citations

This map shows the geographic impact of Jan Best's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Best with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Best more than expected).

Fields of papers citing papers by Jan Best

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Best. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Best. The network helps show where Jan Best may publish in the future.

Co-authors

The 25 scholars most cited alongside Jan Best, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Best Line = papers co-authored together Jan Best links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis Hepatology ·Lars P. Bechmann, Peri Kocabayoglu, Jan‐Peter Sowa, Svenja Sydor, Jan Best, Martin Schlattjan, A Beilfuss, Johannes Schmitt, Rebekka A. Hannivoort, Alpaslan Kılıçarslan, Christian Rust, Frieder Berr, Oliver Tschopp, Guido Gerken, Scott L. Friedman, Andreas Geier, Ali Canbay	2013	187
2	Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC Clinical and Translational Gastroenterology ·Svenja Sydor, Jan Best, I Messerschmidt, Paul Manka, Ramiro Vilchez‐Vargas, Susanne Brodesser, Christina Lucas, A Wegehaupt, C Wenning, S Aßmuth, Simon Hohenester, Alexander Link, Klaas Nico Faber, Han Moshage, Francisco Javier Cubero, Scott L. Friedman, Guido Gerken, Michael Trauner, Ali Canbay, Lars P. Bechmann	2020	92
3	The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma Zeitschrift für Gastroenterologie ·Jan Best, H. Bilgi, Dominik Heider, Clemens Schotten, Paul Manka, Sotiria Bedreli, Michael Gorray, Judith Ertle, Leo A. van Grunsven, Alexander Dechêne	2016	90
4	Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort Scientific Reports ·Julia Kälsch, Lars P. Bechmann, Dominik Heider, Jan Best, Paul Manka, Hagen Kälsch, Jan‐Peter Sowa, Susanne Moebus, U. Slomiany, Karl‐Heinz Jöckel, Raimund Erbel, Guido Gerken, Ali Canbay	2015	58
5	The quest for liver progenitor cells: A practical point of view Journal of Hepatology ·Laurent Dollé, Jan Best, Jie Mei, Feras Al Battah, Hendrik Reynaert, Leo A. van Grunsven, Albert Geerts	2009	55
6	Successful Isolation of Liver Progenitor Cells by Aldehyde Dehydrogenase Activity in Na"ve Mice Hepatology ·Laurent Dollé, Jan Best, Christophe Empsen, Jie Mei, Elke Van Rossen, Philip Roelandt, Sarah Snykers, Mustapha Najimi, Feras Al Battah, Neil D. Theise, Konrad L. Streetz, Étienne Sokal, Isabelle Leclercq, Catherine M. Verfaillie, Vera Rogiers, Albert Geerts, Leo A. van Grunsven	2011	45
7	Steatosis does not impair liver regeneration after partial hepatectomy Laboratory Investigation ·Svenja Sydor, Yanli Gu, Martin Schlattjan, Lars P. Bechmann, Ursula Rauen, Jan Best, Andreas Paul, Hideo A. Baba, Jan‐Peter Sowa, Guido Gerken, Ali Canbay	2012	43
8	A combination of peppermint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model Scandinavian Journal of Gastroenterology ·Birgit Adam, Tobias Liebregts, Jan Best, Lars P. Bechmann, Carolin Lackner, Jens Neumann, Stephan Koehler, Gerald Holtmann	2005	40
9	Role of liver progenitors in acute liver injury Frontiers in Physiology ·Jan Best, Laurent Dollé, Paul Manka, Jason D. Coombes, Leo A. van Grunsven, Wing‐Kin Syn	2013	38
10	Mediation of nitrous oxide analgesia in mice by spinal and supraspinal κ-opioid receptors European Journal of Pharmacology ·Raymond M. Quock, Jan Best, D.C. Chen, Linda K. Vaughn, Philip S. Portoghese, A.E. Takemori	1990	37
11	Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis Digestive Diseases and Sciences ·Paul Manka, Lars P. Bechmann, Jan Best, Svenja Sydor, Lee C. Claridge, Jason D. Coombes, Ali Canbay, Lars C. Moeller, Guido Gerken, Heiner Wedemeyer, Wing‐Kin Syn	2019	37
12	GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients Pharmaceuticals ·Clemens Schotten, Bastian Ostertag, Jan‐Peter Sowa, Paul Manka, Lars P. Bechmann, Gudrun Hilgard, C. Marquardt, Marc Wichert, Hidenori Toyoda, Christian M. Lange, Ali Canbay, Philip J. Johnson, Heiner Wedemeyer, Jan Best	2021	34
13	Novel implications in the treatment of hepatocellular carcinoma Annals of Gastroenterology ·Jan Best	2016	31
14	A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease EBioMedicine ·Joeri Lambrecht, Stefaan Verhulst, Inge Mannaerts, Jan‐Peter Sowa, Jan Best, Ali Canbay, Hendrik Reynaert, Leo A. van Grunsven	2019	31
15	Mitochondrial uncouplers inhibit hepatic stellate cell activation BMC Gastroenterology ·Eduardo Linck Machado Guimarães, Jan Best, Laurent Dollé, Mustapha Najimi, Étienne Sokal, Leo A. van Grunsven	2012	27
16	Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies PLoS ONE ·Jan Best, Stefaan Verhulst, Wing‐Kin Syn, Kimberly Lagaisse, Noémi Van Hul, Femke Heindryckx, Jan‐Peter Sowa, Liesbeth Peeters, Hans Van Vlierberghe, Isabelle Leclercq, Ali Canbay, Laurent Dollé, Leo A. van Grunsven	2016	27
17	Role of liver progenitors in liver regeneration. PubMed ·Jan Best, Paul Manka, Wing‐Kin Syn, Laurent Dollé, Leo A. van Grunsven, Ali Canbay	2015	27
18	Tivantinib for the treatment of hepatocellular carcinoma Expert Opinion on Pharmacotherapy ·Jan Best, Clemens Schotten, Gregor Lohmann, Guido Gerken, Alexander Dechêne	2017	24
19	Epidemiology of nonalcoholic steatohepatitis and hepatocellular carcinoma Clinical Liver Disease ·Christian D. Fingas, Jan Best, Jan‐Peter Sowa, Ali Canbay	2016	23
20	Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration World Journal of Gastroenterology ·Jan‐Peter Sowa, Jan Best, Tamás Benkö, Maximillian Bockhorn, Yanli Gu, Eva-Maria Niehues, Agnieska Bucchi, Eva-Maria Benedetto-Castro, Guido Gerken, Ursula Rauen, JF Schlaak	2008	20

About Jan Best

Jan Best is a scholar working on Hepatology, Epidemiology, Surgery, Gastroenterology and Pharmacology, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (30 papers), Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Liver physiology and pathology (14 papers), Liver Disease and Transplantation (11 papers), Organ Transplantation Techniques and Outcomes (8 papers), Liver Diseases and Immunity (5 papers), Hepatitis B Virus Studies (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Hepatology (551 citations), Epidemiology (688 citations), Cancer Research (120 citations), Oncology (214 citations) and Pharmacology (67 citations). Jan Best has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Ali Canbay, Guido Gerken, Leo A. van Grunsven, Lars P. Bechmann, Paul Manka, Jan‐Peter Sowa, Laurent Dollé, Svenja Sydor, Alexander Dechêne and Wing‐Kin Syn. Their work appears in journals such as Journal of Hepatology, Scientific Reports, Pharmaceuticals, Journal of Clinical Medicine and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact